Showing results (201-210 of 1,045) with videos related to

Sort By:
Pageof 105
Current Protocols in Molecular Biology|February 12, 2008
Methylation and uracil interference assays for analysis of protein-DNA interactionsA S Baldwin, M Oettinger, K Struhl
International Clinical Psychopharmacology|April 7, 2017
Utility of functioning in predicting costs of care for patients with mood and anxiety disorders: a prospective cohort studyConal Twomey, Alarcos Cieza, David S Baldwin
Science'S STKE : Signal Transduction Knowledge Environment|March 31, 2005
Signaling the junctions in gut epitheliumFrédéric Hollande, Arthur Shulkes, Graham S Baldwin
Biochimica Et Biophysica Acta|July 9, 2004
Gastrins, cholecystokinins and gastrointestinal cancerAhmad Aly, Arthur Shulkes, Graham S Baldwin
The Protein Journal|December 11, 2007
Preparation and properties of recombinant rat and human procholecystokinin(57-95)Susann Friedrich, Yulia Sims, Graham S Baldwin
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|September 27, 2003
Chloroplast mutations induced by 9-aminoacridine hydrochloride are independent of the plastome mutator in OenotheraM GuhaMajumdar, S Baldwin, B B Sears
International Clinical Psychopharmacology|April 6, 2012
Lu AA21004, a multimodal psychotropic agent, in the prevention of relapse in adult patients with generalized anxiety disorderDavid S Baldwin, Henrik Loft, Ioana Florea
Biochimica Et Biophysica Acta|June 3, 2008
PAK1 interacts with beta-catenin and is required for the regulation of the beta-catenin signalling pathway by gastrinsHong He, Arthur Shulkes, Graham S Baldwin
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 3, 2012
A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD)David S Baldwin, Henrik Loft, Marianne Dragheim
Pageof 105